Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Atossa Genetics Inc. logo

Atossa Genetics Inc.

Sector: Healthcare   

Industry: Diagnostics & Research

1.50
 
USD
  
0.01
  
(0.67%)
Optionable: Yes  Market Cap: 187 M  90-day average vol: 1,677,808

Previous close: 1.49  Open: 1.48  Bid: 1.48  Ask: 1.5
52 week range    
0.59   
   2.31
Peers   
JNJ / 
LH / 
NEO / 
ENZ / 
Last updated: Thursday 25th April 2024
48
MarketXLS Rank
60
Value
53
Technical
31
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

DGX

0.018817 B8.1132.21

ENZ

0 B32.23.39

JNJ

0.0247450 B22.1171.06

LH

26 B9.6274.56

NEO

3 B60.921.72
Financials

ATOS Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccruedPreferredStockDividends3 M11 M5 M
AcquiredInProcessRnDIncome40138.0
AllowancesForConstruction192817.0
Amortization of intangibles-103038.0-30000.0-30800.041000.054000.0
Basic EPS from continuing operations-1.97-0.18-0.21
Basic EPS total-1.97-0.18-0.21
Basic weighted shares outstanding1 M2 M2 M189814.0974772.04 M8 M11 M116950.0127 M
Cost of sales-105764.0-340658.0-132411.0
Depletion192817.0
Depreciation-82970.0-144896.0-73094.0-125661.0-25956.0-14000.0-22000.019000.010000.0
Depreciation unreconciled192817.0
DepreciationAndAmortization-82970.0-144896.0-73094.0-125661.0-25956.0-14000.0-22000.019000.010000.0
Diluted EPS total-8.4-7.32-6.6-33.6-10.92-5.5-2.03-1.97-0.18-0.21
Diluted normalized net income/share-2.03
Diluted weighted shares outstanding1 M2 M2 M189550.0743826.02 M8 M11 M116950.0127 M
DilutedDiscontinuousOperations-1.2
GainOnSaleOfBusiness-670943.0
GainOnSaleOfSecurity-163333.0
GeneralAndAdministrativeExpense9 M8 M9 M6 M5 M7 M11 M8 M11 M13 M
Gross operating profit137093.040138.0-130653.0
ImpairmentOfCapitalAssets-163333.0
Income before tax-11 M-12 M-13 M-6 M-8 M-11 M-17 M-18 M-21 M-27 M
Income taxes-14202.0-11996.0-2 M
Interest income295.0260.0431.02 M154.06000.0877000.0
InterestExpenseNonOperating360.015769.0
MiscOtherSpecialCharges-280593.029299.025648.0-2 M-91000.0-146000.0
Net income from total operations-11 M-12 M-13 M-6 M-8 M-11 M-17 M-18 M-21 M-27 M
NetIncomeCommonStockholders-11 M-12 M-13 M-6 M-11 M-23 M-17 M-22 M-21 M-27 M
NetIncomeContinuousOperations-11 M-12 M-13 M-6 M-8 M-11 M-17 M-18 M-21 M-27 M
NetIncomeDiscontinuousOperations-2 M-3 M
NetNonOperatingInterestIncomeExpense-65.0260.0431.02 M154.06000.0877000.0
NonRecurringOperationExpense280747.0
Operating income-11 M-10 M-13 M-7 M-7 M-11 M-17 M-15 M-21 M-28 M
Operating income before depreciation (EBITDA)-10 M-12 M-12 M-6 M-8 M-11 M-17 M-18 M-21 M-27 M
OperatingExpense-11 M-12 M-13 M-8 M-8 M-11 M17 M15 M21 M28 M
Other income net-158292.02 M670943.0718970.0742308.0-29299.0-25648.02 M91000.0146000.0
OtherGandA9 M8 M9 M6 M5 M7 M11 M8 M11 M13 M
OtherImpairmentOfCapitalAssets-158292.02 M718970.0461715.0
OtherOperatingExpenses-354861.0-209288.057000.026000.015000.0
OtherunderPreferredStockDividend3 M11 M5 M
PreferredStockDividends3 M11 M5 M
RentAndLandingFees9 M8 M9 M6 M5 M7 M
Research & development expense1 M1 M2 M770427.02 M4 M7 M7 M9 M15 M
ResearchExpense1 M1 M2 M770427.02 M4 M7 M7 M9 M15 M
Revenue per share-103038.0-30000.0-30800.041000.054000.0
SalariesAndWages-1 M-556288.0-840103.0-876189.0-786550.0-1 M-7 M
Selling Gen & administrative expense10 M9 M10 M6 M5 M7 M11 M8 M11 M13 M
SellingAndMarketingExpense1 M695930.01 M
SellingExpense1 M695930.01 M
Special income/charges163333.0-280747.0
Total Income available for interest expense (EBIT)-11 M-12 M-13 M-6 M-8 M-11 M-17 M-18 M-21 M-27 M
Total common shares outstanding135714.0141089.0215685.0315576.03 M9 M9 M121 M127 M
Total net income-11 M-12 M-13 M-6 M-8 M-11 M-17 M-18 M-21 M-27 M
Total ordinary shares125 M125 M125 M125 M125 M125 M125 M125 M125 M125 M
Total revenues482612.0525954.01758.0
TotalExpenses-11 M-12 M-13 M-8 M-8 M-11 M17 M15 M21 M28 M
TotalRevenue632558.040138.01758.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University